This invention relates to novel imidazolidinone prostaglandin compounds of the formula
and the pharmaceutically acceptable salts thereof, wherein A is -C2H4- or -CH=CH-; R1 and R2 are independently hydrogen or alkyl of 1 to 4 carbons; R3 is hydrogen or methyl; and R4 is -(CH2)nCH3 wherein n is 3-7, cycloalkyl of 5-7 carbons, a substituent of the formula
wherein R5 is hydrogen, alkyl of 1 to 4 carbons. alkoxy of 1 to 4 carbons. halo or trifluoromethyl. These compounds are inhibitors of blood platelet aggregation.
本发明涉及式中的新型
咪唑烷酮
前列腺素化合物及其药学上可接受的盐类,其中A为-
C2H4-或-CH=CH-;R1和R2独立地为氢或1至4个碳原子的烷基;R3为氢或甲基;R4为-(
CH2)nCH3(其中n为3-7)、5至7个碳原子的环烷基、式中的取代基(其中R5为氢、1至4个碳原子的烷基、1至4个碳原子的烷氧基、卤代物或三
氟甲基)。 这些化合物是血小板聚集
抑制剂。